Teledyne Technologies Incorporated 2020 Annual Report
Total Page:16
File Type:pdf, Size:1020Kb
2020 Annual Report Innovative and Disciplined GAAP EPS (a) Sales $3,500 $12 $ In Millions $3,164 $3,086 $10.73 $10.62 $ Per Share $3,000 $2,902 $10 $2,604 $9.01 $2,394 $2,500 $2,339 $2,298 $2,127 $2,150 $8 $1,942 $6.26 $2,000 $5.75 $6 $5.44 $5.37 $4.87 $1,500 $4.33 $3.81 $4 $1,000 $2 $500 $0 $0 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 (a) Represents total GAAP earnings per diluted share for 2013 through 2020 and GAAP EPS from continuing operations for 2011 and 2012. Financial Highlights Selected Consolidated Financial Data (In millions, except per share data) Summary Financial Information 2020 2019 2018 2017 2016 Sales $3,086.2 $3,163.6 $2,901.8 $2,603.8 $2,149.9 Net income 401.9 402.3 333.8 227.2 190.9 Diluted earnings per 10.62 10.73 9.01 6.26 5.37 common share Weighted average diluted 37.9 37.5 37.0 36.3 35.5 common shares outstanding Summary Balance Sheet Data 2020 2019 2018 2017 2016 Cash and cash equivalents $673.1 $199.5 $142.5 $70.9 $98.6 Total assets 5,084.8 4,579.8 3,809.3 3,846.4 2,774.4 Long-term debt 680.9 750.0 610.1 1,063.9 509.7 Total equity 3,228.6 2,714.7 2,229.7 1,947.3 1,554.4 See “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the “Notes to Consolidated Financial Statements” in the 2020 Form 10-K for additional information regarding Teledyne Technologies Incorporated’s financial data. 2 Teledyne Technologies 2020 Annual Report 2020 Sales by Segment • Instrumentation Test and measurement, monitoring and control instrumentation, and power and communications connectivity devices for marine, 14% environmental, electronics and other applications • Digital Imaging 35% High performance sensors, cameras and systems within the visible, infrared, ultraviolet and X-ray spectra, used in industrial, government 19% and medical applications • Aerospace and Defense Electronics Sophisticated electronic components, subsystems and communications products, including defense electronics, commercial avionics and harsh environment interconnects 32% • Engineered Systems Innovative systems engineering, manufacturing and specialized products for government, space, energy and industrial customers Cumulative Total Stockholder Return The graph set forth below shows the cumulative total The graph assumes $100 was invested on stockholder return (i.e. price change plus reinvestment of December 31, 2015. dividends) on our common stock for the five fiscal years In accordance with the rules of the SEC, this ending January 3, 2021, as compared to the Standard presentation is not incorporated by reference into & Poor’s 1500 Industrials, the Russell 1000 Index and any of our registration statements under the the Standard & Poor’s 500 Composite. Securities Act of 1933. 500 450 400 350 300 250 200 150 100 50 0 01/03/16 01/01/17 12/31/17 12/30/18 12/29/19 01/03/21 01/03/16 01/01/17 12/31/17 12/30/18 12/29/19 01/03/21 • Teledyne Technologies 100 139 204 229 392 442 • S&P 1500 Industrials 100 120 146 125 165 183 • Russell 1000 100 112 136 129 171 206 • S&P 500 Composite 100 112 136 129 172 203 teledyne.com 3 Improving the Health of People, Places, and the Planet. Teledyne provides innovative products and services that people rely on in their daily lives, in good times and in bad. Continuing themes detailed in the 2018 and 2019 Annual Reports, this year we’d like to address the unprecedented set of challenges the world faced in 2020. Record-setting hurricanes, fires, floods, and a global pandemic all challenged the very core of our way of life. As an Essential Business, Teledyne has been here, working around the clock, in order to meet those challenges today, and into the future. We have previously written about our enabling technologies for many essential applications including water and air quality, toxic gas detection, hurricane forecasting, earth observation from space, transportation safety, infrastructure inspection, and national security. But did you know that our technologies also enable human health applications ranging from scientific research to clinical therapies and public health? 4 Teledyne Technologies 2020 Annual Report Research and Development Enabling Rapid, Low Cost DNA Testing DNA, or deoxyribonucleic acid, contains the instructions for an organism to develop, survive and reproduce itself. Life science researchers rely on DNA testing to identify genetic variations associated with diseases. The advent of affordable rapid DNA testing methods has greatly accelerated research and discovery. According to the National Institutes of Health, the cost of DNA testing has declined by a factor of over 100,000 since 2001. Teledyne has helped enable this transformation by developing automated microfabrication technology to produce millions of microarrays for DNA sensors. We are working with major DNA instrument companies supporting the fabrication of next generation sensors that will extend applications to precision medicine, consumer screening, and agriculture. Optical Imaging of Living Organisms Visualizing biological processes and disease progression through optical imaging of living organisms, known as in vivo imaging, is crucial in the study and evaluation of potential drug candidates early in their development stage. The primary aim of these studies is to determine the efficacy, safety, dosing, and toxicity of potential new drugs before human trials begin. Our Above: Teledyne scientific cameras excel in optimized scientific cameras are specifically Fluorescence Lifetime Imaging Microscopy, used engineered to capture high resolution images in cell biology to study metabolic states of cells in the extreme low light environments required and tissues. for accurate evaluation. We also enable real time Left: Teledyne makes both the MEMS microarrays imaging deep into tissue with infrared imaging that hold samples of DNA for analysis and high sensors. performance cameras that read the faint, microscopic signals that mark genetic sequences. teledyne.com 5 Accelerating Pharmaceutical Assuring Pharmaceutical Quality Development Our pharmaceutical testing instruments are Pharmaceutical researchers need to purify used in drug research and development, organic compounds during drug discovery. manufacturing and quality control facilities This was once a time-consuming process, but to ensure pharmaceutical products conform Teledyne’s chromatography systems enable to strict requirements for dosage uniformity, researchers to rapidly purify compounds, tablet hardness, disintegration, and dissolution including those used in critical batches of (release-rate), and to ensure semisolid topical COVID-19 vaccines. formulations and transdermal drug delivery products such as creams, ointments, and gels perform properly when applied to the skin. 6 Teledyne Technologies 2020 Annual Report Medical Diagnostics Faster Examination of Biomedical Samples Pathologists use microscopes to examine tissue samples and fluids to diagnose diseases. Manual microscopes permit examination of about 350 sections of human tissue per day; but with the power of automation, an optical digital pathology system can scan as many as 3,600 sections per hour, or more than 28,000 per day. The resulting images are far more detailed, more easily and more reliably transferred, and capable of revealing cancerous cells and even malignant cells that may still exist in tissue after chemotherapy treatment. Our fast, ultra-high-resolution cameras and sensors deliver clarity and increased throughput to digital pathology labs. Above: A lab technician is using a Flash Chromatography system to help speed up the purification process in the discovery and development of new drugs and treatments. Left Page: Dissolution testing systems are used worldwide for precision release-rate testing of pharmaceutical products. Above: Pathologists use tissue samples like this one, from a laryngeal chondrosarcoma, to identify and study diseases. teledyne.com 7 Clinical Treatment and Therapy Reliable Worldwide Radiotherapy The impact of cancer is both near-universal and intensely personal—rare are the families who have not been impacted by it. The need for cancer screening and therapy will only grow and we are proud to enable both diagnosis and treatment. Our products generate and deliver the microwave power required by the linear accelerators within radiotherapy cancer treatment machines, producing the X-rays used in both the imaging and radiation treatment of tumors. Teledyne products power 90% of the world’s radiotherapy systems, enabling precise radiation therapy to treat and defeat malignant cancer. Lower Dose X-ray Sensors X-ray imaging is an indispensable tool for many diagnostic and interventional medical procedures in both hard and soft tissue. Orthopedic surgeons depend on it when setting fractures; oncologists rely on it in mammography to identify calcifications and to guide stereotactic biopsy needles. Dentists use it daily to find cavities and plan orthodontics. In these applications, the low-dose sensitivity of Teledyne’s X-ray detectors clearly shows our leadership. We deliver better images at lower X-ray doses, benefiting both patients and practitioners. The advantages we bring are multiplied in fluoroscopy (X-ray video) applications such as angiography, catheter placement, heart valve replacement and other minimally invasive surgery; because every frame requires less dose, the cumulative dose is dramatically lower than with competing technologies. Above: Teledyne’s X-ray detectors, used in surgical, orthopedic, and dental applications, provide higher quality images at lower X-ray doses. Right: We have designed and manufactured magnetrons for over 60 years, delivering microwave power to drive linear accelerators for radiotherapy systems that destroy cancer cells. 8 Teledyne Technologies 2020 Annual Report Public Health and Safety Protecting the Integrity of the World’s Food Supply The World Health Organization estimates that 600 million people fall ill and 420,000 die every year after eating contaminated food.